The global autoinjectors market is driven by growing popularity of targeted therapies and increasing number of regulatory approvals. Moreover increasing incidences of anaphylaxis, availability of generic versions of autoinjectors and growing geriatric population is anticipated to further contribute to the growing demand of the global autoinjectors market during the forecast period. However, availability of conventional drug delivery systems like syringes s likely to restrain the market to a certain extent.
Major Key Players of the Autoinjectors Market are:
Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton Dickinson and Company, Owen Mumford, Consort Medical, Haselmeier and Shl Group among others.
The advent of novel technologies in the field of autoinjectors has been pivotal in contributing to the growing demand of these devices worldwide. Adoption of latest technologies like variable dose drug delivery and feedback mechanism on time and dosage of drugs have been extremely beneficial in supporting the growth of this industry. For instance, SmartPilot technology for YpsoMate product line, manufactured by Ypsomed AG, offers several advanced features which enables administration of drugs with better efficiency and efficacy. Features like drug identification, reminder of injection time and date, variable dosage delivering capacity and feedback systems have raised the standards of drug delivery technologies, which is further anticipated mature in the coming years.
The Autoinjectors Market is segmented on the basis of Therapy, Types, End Users and region.
Major Therapy of Autoinjectors Market covered are:
- Rheumatoid Arthritis
- Multiple Sclerosis
- Diabetes
- Anaphylaxis
Major Types of Autoinjectors Market covered are:
- Disposable
- Reusable
Major End Users of Autoinjectors Market covered are:
- Home Care Settings
- Hospitals
- Clinics
No comments:
Post a Comment